Eurostars Grant for Novio Catalpa Consortium together with Medipan GmbH and Radboud University

By |2025-10-10T10:27:37+01:00October 9th, 2025|

Your Content Goes Here One of the 30 most promising innovations among all Eurostars submissions in 2025. The Novio Catalpa consortium has been selected as one of the 30 most promising innovations among all Eurostars submissions in 2025. The grant will be used to further develop our platform technology for the [...]

Novio Catalpa will present at the 17th Dresden Symposium of Autoantibodies

By |2025-08-22T11:06:57+01:00May 22nd, 2025|

Novio Catalpa will present at the 17th Dresden Symposium of Autoantibodies The 17th Dresden Symposium on Autoantibodies will take place from September 9 to September 12, at the Dresden Fair, Germany. The congress is entitled: The Autoantibody Spectrum: Bridging Health, Diagnostics, and Disease. This four-day event will feature recent findings from leading industrial, [...]

Presentation among world-leading experts at the EMBO Workshop

By |2025-02-04T15:40:32+01:00June 13th, 2024|

Your Content Goes Here Presentation among world-leading experts at the EMBO Workshop Our Advisory Board member Prof. Dr. Ger Pruijn will be one of the speakers at the EMBO Workshop from 8 to 11 July in Toulouse. He was invited following the selection of the Abstract: ‘Rapid detection of anti-citrullinated protein [...]

Collaboration with HAN BioCentre

By |2021-09-07T09:06:44+01:00February 3rd, 2021|

Collaboration with HAN BioCentre Novio Catalpa has established a collaboration with HAN BioCentre, a Centre of Expertise in Applied Biosciences and Chemistry. The collaboration aims to develop and manufacture Novio Catalpa’s diagnostic nanobodies for a rapid agglutination assay that will offer an innovative approach in Rheumatoid Arthritis diagnosis. HAN BioCentre will [...]

Go to Top